Pure Bioscience Inc   (PURE)

Inconsequential dip in the Top-line at Pure Bioscience Inc all along the second quarter of 2023

Pure Bioscience Inc announced second quarter of 2023 operating shortfall of $-1.058 millions

Published Mar 25 2023
Goran Soko / CSIMarket.com Contributer

ShellMartinez-refi_User.Leonard_G_ _[CC-BY-SA-1.0_(http_creativecommons.org_licenses_by-sa_1.0)]_via_Wikimedia_CommonFor the fiscal interval ending January 31 2023 Pure Bioscience Inc lost money of $-0.01 per share compare to $-0.01 a year ago and from $-0.01 per share from the previous reporting season.

Revenues contracted by -4.567 % to $0.40 millions from $0.42 millions in the similar reporting season a year ago and sequentially Revenues fell by -15.711 % from $0.47 millions.

For the fiscal interval ending January 31 2023 Pure Bioscience Inc realized net shortfall of $-1.060 million, bigger than $-0.702 million a year ago.

Pure Bioscience Inc is expected to report next financial earnings on June 13, 2023.

Pure Bioscience Inc's Receivables Turnover Ratio

Pure Bioscience Inc's Free Cash Flow Margin


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071